ASCO's CancerLinQ, Atropos Partner on ‘Prognostrogram’ Reports

Writing for Healthcare Innovation, David Raths discusses our new partnership with ASCO Cancerlinq; some highlights below:

The American Society of Clinical Oncology’s CancerLinQ is partnering with Atropos Health in an effort to provide oncology clinicians with the latest real-world evidence available to help inform personalized care and treatment of an individual patient.

…

“At CancerLinQ, we are guided by our commitment to deliver solutions to oncologists that improve the quality of care for patients in concrete and measurable ways,” said Sean Khozin, M.D., M.P.H., chief executive officer of CancerLinQ, in a statement. “Our collaboration with Atropos Health will enable us to provide high-quality real-world evidence derived from diverse patient populations to help oncologist individualize treatment decisions at the point of care.”